Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population

Journal of Experimental Medicine

Volumn 189, Issue 9, 1999, Pages 1413-1423

  Vink, Anne ^a   Warnier, Guy ^a   Brombacher, Frank ^b   Renauld, Jean Christophe ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Autoimmunity; B 1 lymphocytes; Cytokines; Transgenic mice

Indexed keywords

AUTOANTIBODY; CD5 ANTIGEN; COMPLEMENTARY DNA; INTERLEUKIN 9; RECOMBINANT INTERLEUKIN 9;

ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; CELL COUNT; FEMALE; IMMUNOGLOBULINS; INTERLEUKIN-5; INTERLEUKIN-9; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERITONEUM; RECEPTORS, INTERLEUKIN;

EID: 0033519305     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.9.1413     Document Type: Article

References (41)

1. Renauld, J.-C., and J. Van Snick. 1998. Interleukin-9. In The Cytokine Handbook, 3rd ed. A. Thompson, editor. Academic Press, Inc., New York. 313-331.
2. Merz, H., F.A. Houssiau, K. Orscheschek, J.-C. Renauld, A. Fliedner, M. Herin, H. Noel, M. Kadin, H.K. Mueller-Hermelink, J. Van Snick, and A.C. Feller. 1991. IL-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood. 78:1311-1317.
3. Renauld, J.-C., N. van der Lugt, A. Vink, M. van Roon, C. Godfraind, G. Warnier, H. Merz, A. Feller, A. Berns, and J. Van Snick. 1994. Thymic lymphomas in interleukin 9 transgenic mice. Oncogene. 9:1327-1332.
4. Marsh, D.G., J.D. Neely, D.R. Breazeale, B. Ghosh, L.R. Freidhoff, E. Ehrlich-Kautzky, C. Schou, G. Krishnaswamy, and T.H. Beaty. 1994. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum IgE. concentrations. Science. 264:1152-1156.
5. Postma, D.S., E.R. Beecker, P.J. Amelung, K.J. Holroyd, J. Xu, C.I. Panhuysen, D.A. Meyers, and R.C. Levitt. 1995. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N. Engl. J. Med. 333:894-900.
6. Holroyd, K.J., L.C. Martinati, E. Trabetti, T. Scherpbier, S.M. Eleff, A.L. Boner, P.F. Pignatti, M.B. Kiser, C.R. Dragwa, and F. Hubbard. 1998. Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region. Genomics. 52:233-235.
7. Nicolaides, N., K.J. Holroyd, S.L. Ewart, S.M. Eleff, M.B. Kiser, C.R. Dragwa, C.D. Sullivan, L. Grasso, L.Y. Zhang, C.J. Messler, et al. 1997. Interleukin 9: a candidate gene for asthma. Proc. Nad. Acad. Sci. USA. 94:13175-13180.
8. Godfraind, C., J. Louahed, H. Faulkner, A. Vink, G. Warnier, R. Grencis, and J.-C. Renauld. 1998. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice J. Immunol. 160:3989-3996.
9. Temann, U.A., G.P. Geba, J.A. Rankin, and R.A. Flavell. 1998. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188:1307-1320.
10. Dugas, B., J.-C. Renauld, J. Pène, J.Y. Bonnefoy, C. Petit-Frère, P. Braquet, J. Bousquet, J. Van Snick, and J.-M. Mencia-Huerta. 1993. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur. J. Immunol. 23:1687-1692.
11. Petit-Frère, C., B. Dugas, P. Braquet, and J.-M. Mencia-Huerta. 1993. Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology. 79:146-151.
12. Jeannin, P., Y. Delneste, S. Lecoanet-Henchoz, D. Gretener, and J.Y. Bonnefoy. 1998. Interleukin-7 (IL-7) enhances class switching to IgE in the presence of T cells via IL-9 and sCD23. Blood. 91:1355-1361.
13. Druez, C., P. Coulie, C. Uyttenhove, and J. Van Snick. 1990. Functional and biochemical characterization of mouse P40/IL-9 receptors. J. Immunol. 145:2494-2499.
14. Kopf, M., F. Brombacher, P.D. Hodgkin, A.J. Ramsay, E.A. Milbourne, W.J. Dai, K.S. Ovington, C.A. Behm, G. Kohler, I.G. Young, and K.I. Matthaei. 1996. IL-5-deficient mice have a developmental defect in CDS+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 4:15-24.
15. Gajewski, T.F., F. Fallarino, C. Uyttenhove, and T. Boon. 1996. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor. Superiority of B7-1 over B7-2 for active tumor immunization. J. Immunol. 156:2909-2917.
16. Coutelier, J.P., E. Van Roost, P. Lambotte, and J. Van Snick. 1986. The murine antibody response to lactate dehydrogenase-elevating virus. J. Gen. Virol. 67:1099-1108.
17. Coutelier, J.-P., P.G. Coulie, P. Wauters, H. Heremans, and J. van der Logt. 1990. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J. Virol. 64:5383-5388.
18. Van Snick, J., and P. Masson. 1979. Age-dependent production of IgA and IgM autoantibodies against IgG2a in a colony of 129/Sv mice. J. Exp. Med. 149:1519-1530.
19. Hardy, R.R., C.E. Carmack, S.A. Shinton, R.J. Ribblet, and K. Hayakawa. 1989. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J. Immunol. 142: 3643-3651.
20. Cunningham, A.J. 1974. Large numbers of cells in normal mice produce antibody components of isologous erythrocytes. Nature. 252:749-751.
21. Poncet, P., F. Huetz, M.-A. Marcos, and L. Andrade. 1990. All VH11 genes expressed in peritoneal lymphocytes encode anti-bromelain-treated mouse red blood cell autoantibodies but other VH gene families contribute to this specificity. Eur. J. Immunol. 20:1583-1589.
22. Kantor, A.B., and L.A. Herzenberg. 1993. Origin of murine B cell lineages. Annu. Rev. Immunol. 11:501-538.
23. Hardy, R.R., and K. Hayakawa. 1994. CD5 B cells, a fetal B cell lineage. Adv. Immunol. 55:297-339.
24. Wetzel, G.D. 1989. Interleukin 5 regulation of peritoneal Ly-1 B lymphocyte proliferation, differentiation and autoantibody secretion. Eur. J. Immunol. 19:1701-1707.
25. Tominaga, A., S. Takaki, N. Koyama, S. Katoh, R. Matsumoto, M. Migita, Y. Hitoshi, Y. Hosoya, S. Yamauchi, Y. Kanai, et al. 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173:429-437.
26. Hitoshi, Y., N. Yamaguchi, S. Mita, E. Sonoda, S. Takaki, A. Tominaga, and K. Takatsu. 1990. Distribution of IL-5 receptor positive B cells. Expression of IL-5 receptor on Ly-1 (CDS)+ B cells. J. Immunol. 144:4218-4225.
27. Bao, S., K.W. Beagley, A.M. Murray, V. Caristo, K.I. Matthaei, I.G. Young, and A.J. Husband. 1998. Intestinal IgA plasma cells of the B1 lineage are IL-5 dependent. Immunology. 94:181-188.
28. Hayakawa, K., R.R. Hardy, M. Honda, L.A. Herzenberg, A.D. Steinberg, and L.A. Herzenberg. 1984. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoanti-bodies. Proc. Natl. Acad. Sci. USA. 81:2494-2498.
29. Hayakawa, K., C.E. Carmack, R. Hyman, and R.R. Hardy. 1990. Natural autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein. J. Exp. Med. 172:869-878.
30. Richard, R.R., K. Hayakawa, M. Shimizu, K. Yamasaki, and T. Kishimoto. 1987. Rheumatoid factor secretion from human Leu-1+ B cells. Science. 329:81-83.
31. Izui, S., R.A. Eisenberg, and F.J. Dixon. 1979. IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J. Immunol. 122:2096-2102.
32. Hayakawa, K., R.R. Hardy, D.R. Parks, and L.A. Herzenberg. 1983. The "Ly-1 B" cell subpopulation in normal, immunodefective, and autoimmune mice. J. Exp. Med. 157: 202-218.
33. Sato, S., N. Ono, D.A. Steeber, D.S. Pisetsky, and T.F. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157:4371-4378.
34. Shultz, L.D., P.A. Schweitzer, T.V. Rajan, T. Yi, J.N. Ihle, R.J. Matthews, M.L. Thomas, and D.R. Beier. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 73:1445-1454.
35. Khan, W.N., F.W. Alt, R.M. Gerstein, B.A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Müller, A.B. Kantor, L.A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity. 3:283-299.
36. Tarakhovsky, A., M. Turner, S. Shaal, P.J. Mee, L.P. Duddy, K. Rajewsky, and V. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of vav. Nature. 373:467-470.
37. Zhang, R., F.W. Alt, L. Davidson, S.H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav protooncogene. Nature. 374:470-473.
38. + (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J. Exp, Med. 168: 687-698.
39. Sidman, C.L., L.D. Shultz, R.R. Hardy, K. Hayakavva, and L.A. Herzenberg. 1986. Production of immunoglobulin isotypes by Ly-1 + B cells in viable motheaten and normal mice. Science. 232:1423-1425.
40. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
41. Lalor, P.A., L.A. Herzenberg, S. Adams, and A.M. Stall. 1989. Feedback regulation of murine Ly-1 B cell development. Eur. J. Immunol. 19:507-513.